Considerations for AAV Immunogenicity from a Gene Editing Perspective
Time: 12:30 pm
day: Conference Day Two
Details:
- Complexities of AAV mediated gene therapy
- Immunogenicity risk assessment
- Bioanalytical strategies to monitor AAV gene therapy associated immunogenicity
